The US Cystic Fibrosis Foundation has guidelines for culturing respiratory tract specimens
from patients with cystic fibrosis. Pulmonary physicians were surveyed regarding their
use of these extensive cystic fibrosis culture protocols for patients without cystic
fibrosis. The survey results and a discussion of the implications of these practices
are reported.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Infection ControlAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.Infect Control Hosp Epidemiol. 2003; 24: S6-52
- Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.Chest. 2007; 132: 1565-1572
- Update on non-cystic fibrosis bronchiectasis.Curr Opin Pulm Med. 2008; 14: 595-599
- British Thoracic Society guideline for non-CF bronchiectasis.Thorax. 2010; 65: i1-58
- Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.Thorax. 2013; 68: 731-737
- Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.J Antimicrob Chemother. 2009; 63: 728-732
- Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006.Chest. 2010; 138: 944-949
- Prolonged antibiotics for purulent bronchiectasis in children and adults.Cochrane Database Syst Rev. 2007; : CD001392
- Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008.Pediatr Pulmonol. 2010; 45: 363-370
- Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis.Chest. 2003; 123: 1495-1502
- Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis.J Clin Microbiol. 2006; 44: 1547-1549
Article info
Footnotes
Conflicts of interest: None to report.
Identification
Copyright
© 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
